Qingdao Haier BiomedicalLtd (688139) Stock Overview
Engages in the design, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
688139 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Qingdao Haier Biomedical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥32.82 |
| 52 Week High | CN¥41.86 |
| 52 Week Low | CN¥23.96 |
| Beta | 0.66 |
| 1 Month Change | -1.68% |
| 3 Month Change | 6.56% |
| 1 Year Change | 29.11% |
| 3 Year Change | -48.49% |
| 5 Year Change | n/a |
| Change since IPO | -57.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| 688139 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 0.2% | 1.3% | -1.6% |
| 1Y | 29.1% | 28.9% | 52.3% |
Return vs Industry: 688139 matched the CN Medical Equipment industry which returned 28.9% over the past year.
Return vs Market: 688139 underperformed the CN Market which returned 52.3% over the past year.
Price Volatility
| 688139 volatility | |
|---|---|
| 688139 Average Weekly Movement | 3.1% |
| Medical Equipment Industry Average Movement | 4.9% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in CN Market | 8.8% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 688139 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688139's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 2,866 | Zhanjie Liu | www.haierbiomedical.com |
Qingdao Haier Biomedical Co.,Ltd engages in the design, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers automatic liquid handling workstations; active temperature controlled RKN Containers; biomedical, cryo, controlled rate, plasma, ULT, and vaccine freezers; blood bank, laboratory, pharmacy, and vaccine refrigerators; blood/fluid warming and biological safety cabinets; backup systems; clean bench and laminar flow products; centrifuge products; consumables; cold/freezer rooms; vertical autoclaves; health care solutions; incubators; fully-automated sample processing system; liquid nitrogen storage solutions; plasma apheresis systems; transport coolers; and vaccine safety solutions. It also provides blood, vaccine, reagent, sample, and laboratory network solutions in agri and animal health sectors.
Qingdao Haier Biomedical Co.,Ltd Fundamentals Summary
| 688139 fundamental statistics | |
|---|---|
| Market cap | CN¥10.28b |
| Earnings (TTM) | CN¥275.03m |
| Revenue (TTM) | CN¥2.26b |
Is 688139 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688139 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.26b |
| Cost of Revenue | CN¥1.20b |
| Gross Profit | CN¥1.06b |
| Other Expenses | CN¥780.37m |
| Earnings | CN¥275.03m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 46.78% |
| Net Profit Margin | 12.19% |
| Debt/Equity Ratio | 0.4% |
How did 688139 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/09 22:54 |
| End of Day Share Price | 2025/09/09 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Qingdao Haier Biomedical Co.,Ltd is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Zhu Chen | Citic Securities Co., Ltd. |
| Shuo Song | Citic Securities Co., Ltd. |